Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Clinical features, HSCT indications and outcome of HSCT in Ras-Associated Autoimmune Leukoproliferative Disorder (RALD), a joint ESID/EBMT IEWP study

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Alexandra Laberko, Srividhya Senthil, Andrew Gennery

Clinical presentations, treatments, and outcomes in an international cohort with ZNFX1 deficiency

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Outcomes of Haematopoietic Stem Cell Transplant for MHC Class II deficiency

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Kanchan Rao and Isabelle Meyts

Allogeneic haematopoietic stem cell transplantation in infantile osteopetrosis

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Stem cell transplantation for ALK-pos. and ALK-neg. anaplastic large cell lymphoma: a retrospective analysis of the EBMT-Lymphoma Working Party

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Evgenii SHUMILOV & Dr. Norbert SCHMITZ

Use of regulatory T cells for GvHD prophylaxis and therapy in Europe

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Federico Simonetta

Exploring the Role of AlloHCT in the Modern Era of R/R Mantle Cell Lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Nora LIEBERS & Dr. Sascha DIETRICH

Outcomes after CAR T-cell therapy in Primary Mediastinal B-Cell Lymphoma: a real-world study of the Lymphoma Working Party of the EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Dr. Remy DULERY

LA-DP Immunopeptidome Divergence Predicts CD4⁺ T-Cell Alloreactivity and Outcome of Hematopoietic Cell Transplantation

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Leucémie Aiguë Lymphoblastique (LAL)

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Peter van Balen & Liesbeth de Wreede

Real-World Use of Post-Transplant Cyclophosphamide (PTCy) for Graft-Vs-Host-Disease (GVHD) Prophylaxis in Transplant Centers

Toutes les maladies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Outcomes of patients over 70 years treated with brexucabtagene autoleucel for relapsed refractory mantle cell lymphoma: a study from the CTIWP of EBMT

Retrospective Studies

Other myeloid or lymphoid malignancies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Comparison of outcomes of immune-suppression therapy and stem cell transplant using RACE trial data and a registry transplant cohort

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Immunosuppressive Treatment (IST)

Investigateur principal

Simona Iacobelli, Antonio Risitano